EP 2542242 A1 20130109 - A3AR AGONISTS FOR THE TREATMENT OF UVEITIS
Title (en)
A3AR AGONISTS FOR THE TREATMENT OF UVEITIS
Title (de)
A3AR-AGONISTEN ZUR BEHANDLUNG VON UVEITIS
Title (fr)
AGONISTES A3AR DANS LE CADRE DU TRAITEMENT DE L'UVÉITE
Publication
Application
Priority
- US 31004310 P 20100303
- IL 2011000193 W 20110227
Abstract (en)
[origin: WO2011107981A1] The present disclosure relates to the use of an A3AR agonist, such as IB-MECA, for the treatment or prevention of uveitis in a subject, as well as to methods for such treatment and pharmaceutical compositions comprising an amount of IB-MECA effective to treat uveitis.
IPC 8 full level
A61K 31/52 (2006.01); A61K 31/00 (2006.01); A61K 31/7076 (2006.01); A61P 27/02 (2006.01)
CPC (source: EP KR US)
A61K 31/00 (2013.01 - EP US); A61K 31/52 (2013.01 - EP KR US); A61K 31/7076 (2013.01 - EP KR US); A61P 27/02 (2017.12 - EP); A61P 43/00 (2017.12 - EP); A61K 9/0048 (2013.01 - EP US); A61K 9/2059 (2013.01 - EP US)
Citation (search report)
See references of WO 2011107981A1
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
DOCDB simple family (publication)
WO 2011107981 A1 20110909; CA 2790869 A1 20110909; CN 102905708 A 20130130; EP 2542242 A1 20130109; JP 2013521274 A 20130610; KR 20130072189 A 20130701; MX 2012010006 A 20130117; RU 2012138043 A 20140410; US 2013045943 A1 20130221
DOCDB simple family (application)
IL 2011000193 W 20110227; CA 2790869 A 20110227; CN 201180012191 A 20110227; EP 11710888 A 20110227; JP 2012555540 A 20110227; KR 20127024527 A 20110227; MX 2012010006 A 20110227; RU 2012138043 A 20110227; US 201113581884 A 20110227